Target Price | $18.67 |
Price | $17.40 |
Potential |
7.28%
register free of charge
|
Number of Estimates | 9 |
9 Analysts have issued a price target STAAR Surgical Company 2026 .
The average STAAR Surgical Company target price is $18.67.
This is
7.28%
register free of charge
$27.00
55.17%
register free of charge
$13.00
25.29%
register free of charge
|
|
A rating was issued by 13 analysts: 3 Analysts recommend STAAR Surgical Company to buy, 9 to hold and 1 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the STAAR Surgical Company stock has an average upside potential 2026 of
7.28%
register free of charge
|
Dec '24 |
2025 Estimates |
|
---|---|---|
Revenue Million $ | 313.90 | 260.72 |
2.64% | 16.94% | |
EBITDA Margin | -1.82% | -13.91% |
117.69% | 663.35% | |
Net Margin | -6.44% | -22.82% |
197.94% | 254.46% |
13 Analysts have issued a sales forecast STAAR Surgical Company 2025 . The average STAAR Surgical Company sales estimate is
This results in the following potential growth metrics:
9 Analysts have issued an STAAR Surgical Company EBITDA forecast 2025. The average STAAR Surgical Company EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
11 STAAR Surgical Company Analysts have issued a net profit forecast 2025. The average STAAR Surgical Company net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Dec '24 |
2025 Estimates |
|
---|---|---|
Earnings Per Share $ | -0.41 | -1.21 |
195.35% | 195.12% | |
P/E | negative | |
EV/Sales | 2.56 |
11 Analysts have issued a STAAR Surgical Company forecast for earnings per share. The average STAAR Surgical Company EPS is
This results in the following potential growth metrics and future valuations:
STAAR Surgical Company...
Analyst | Rating | Action | Date |
---|---|---|---|
Stephens & Co. |
Locked
➜
Locked
|
Locked | Mar 18 2025 |
Needham |
Locked
➜
Locked
|
Locked | Feb 27 2025 |
Canaccord Genuity |
Locked
➜
Locked
|
Locked | Feb 13 2025 |
Needham |
Locked
➜
Locked
|
Locked | Feb 12 2025 |
Piper Sandler |
Locked
➜
Locked
|
Locked | Feb 12 2025 |
Stephens & Co. |
Locked
➜
Locked
|
Locked | Feb 12 2025 |
Stifel |
Locked
➜
Locked
|
Locked | Feb 12 2025 |
Analyst Rating | Date |
---|---|
Locked
Stephens & Co.:
Locked
➜
Locked
|
Mar 18 2025 |
Locked
Needham:
Locked
➜
Locked
|
Feb 27 2025 |
Locked
Canaccord Genuity:
Locked
➜
Locked
|
Feb 13 2025 |
Locked
Needham:
Locked
➜
Locked
|
Feb 12 2025 |
Locked
Piper Sandler:
Locked
➜
Locked
|
Feb 12 2025 |
Locked
Stephens & Co.:
Locked
➜
Locked
|
Feb 12 2025 |
Locked
Stifel:
Locked
➜
Locked
|
Feb 12 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.